In studies of diagnostic test accuracy, authors sometimes report results only for a range of cutoff points around data-driven "optimal" cutoffs. We assessed selective cutoff reporting in studies of the diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9) depression screening tool. We compared conventional meta-analysis of published results only with individual-patient-data meta-analysis of results derived from all cutoff points, using data from 13 of 16 studies published during 2004-2009 that were included in a published conventional metaanalysis. For the "standard" PHQ-9 cutoff of 10, accuracy results had been published by 11 of the studies. For all other relevant cutoffs, 3-6 studies published accuracy results. For all cutoffs examined, specificity estimates in conventional and individual-patient-data meta-analyses were within 1% of each other. Sensitivity estimates were similar for the cutoff of 10 but differed by 5%-15% for other cutoffs. In samples where the PHQ-9 was poorly sensitive at the standard cutoff, authors tended to report results for lower cutoffs that yielded optimal results. When the PHQ-9 was highly sensitive, authors more often reported results for higher cutoffs. Consequently, in the conventional metaanalysis, sensitivity increased as cutoff severity increased across part of the cutoff range-an impossibility if all data are analyzed. In sum, selective reporting by primary study authors of only results from cutoffs that perform well in their study can bias accuracy estimates in meta-analyses of published results. bias; depression; diagnostic test accuracy; individual-patient-data meta-analysis; meta-analysis; screening; selective cutoff reporting Abbreviations: CI, confidence interval; IPD, individual patient data; MDD, major depressive disorder; PHQ-9, Patient Health Questionnaire-9.
their most recent guideline (12) . In their recommendation, the Canadian Task Force raised the concern that existing research may exaggerate the diagnostic accuracy of depression screening tools (12) .
To date, there are no clinical trials that have randomized untreated patients prior to screening for depression and then provided the same depression treatment to patients identified as depressed in both unscreened and screened trial arms (13) . If published evidence concerning the diagnostic accuracy of depression screening tools is indeed exaggerated, the potential effectiveness of screening programs that are currently in place might be dramatically different than expected. Exaggerated estimates of accuracy could lead to inappropriate clinical decisions, including a potentially high rate of overdiagnosis and, subsequently, overtreatment (14, 15) .
One mechanism by which publications of research studies could overstate diagnostic accuracy is selective reporting. Selective reporting occurs when multiple analyses are conducted in a study and the decision regarding which findings to report depends on the results (16) . The selective reporting of statistically significant, favorable outcomes and nonreporting of nonsignificant outcomes is well-established as an important source of bias in clinical trials (16) (17) (18) (19) (20) (21) , but the issue has received less attention in studies of diagnostic test accuracy. Selective reporting may occur in these studies when different cutoff thresholds can be used to classify test results as positive versus negative. Often, only results from a single cutoff point, selected from multiple possible cutoffs, are reported in published studies. If reported cutoffs are selected on the basis of maximizing accuracy estimates, then resulting accuracy estimates will tend to overestimate what would occur in practice. The same problem may arise when results for a small range of cutoffs around the optimal cutoff are reported.
Generally accepted "standard" cutoffs have been published for many depression screening tools. These are often based, however, on early studies that included too few depression cases to inspire confidence that the best cutoff was identified (22, 23) . Meta-analyses have the potential to overcome limitations due to small samples in primary studies. However, their results are likely to be biased if primary studies selectively publish results from cutoffs that optimize accuracy. Selective cutoff reporting may be common in studies of depression screening tools. For instance, in a meta-analysis of the depression subscale of the Hospital Anxiety and Depression Scale, Brennan et al. (24) excluded 16 of 41 (39%) otherwise eligible studies because the studies only reported results from study-specific optimal cutoffs and not from standard cutoffs, which were meta-analyzed. In another example, in a meta-analysis of Patient Health Questionnaire-9 (PHQ-9), Manea et al. (25) evaluated sensitivity and specificity for cutoffs of 7-15, including the standard cutoff of 10 (23, 26-29) . Sensitivity and specificity were estimated at each cutoff by analyzing data from all primary studies that reported results for the cutoff. Due to incomplete reporting, however, estimates of sensitivity actually improved as cutoffs increased from 9 (less severe symptoms) to 11 (more severe symptoms). This would be mathematically impossible if complete data were analyzed.
To our knowledge, no studies have examined patterns of selective cutoff reporting in studies of the diagnostic accuracy of depression screening tools or how selective cutoff reporting may influence results. Thus, in the present study, we reanalyzed studies included in the most recently published meta-analysis of the PHQ-9 (25), which included only published results. Our objective was to dissect how bias operates by comparing findings from a conventional meta-analysis of published results with findings from an individual-patient-data (IPD) metaanalysis of both published and unpublished results. For every potentially relevant cutoff, we assessed how reporting choices were associated with perceived sensitivity, specificity, overall diagnostic performance, and heterogeneity.
METHODS

Data source
The PHQ-9 (23, 28, 29 ) is a 9-item measure of depressive symptoms that is increasingly being used in medical populations (26, 27) . The maximum score is 27, and higher scores represent more severe symptoms. The standard cutoff for identifying possible depression is a score of 10 (23, (26) (27) (28) (29) ; this originates from the first PHQ-9 study, which included only 41 depression cases (total n = 580) (23, 29) .
We used the most recently published PHQ-9 meta-analysis (25) as a framework to explore bias related to selective cutoff reporting. Studies were eligible for the original meta-analysis (25) if they 1) defined major depressive disorder (MDD) according to a standard classification system; 2) used a validated diagnostic interview for MDD as the reference standard; and 3) provided sufficient data to construct 2 × 2 contingency tables. The meta-analysis included 18 primary studies with 17 unique patient samples. One study, however, did not publish accuracy results and was included by integrating individual patient data. Thus, there were 16 unique studies with published results available for assessment of selective cutoff reporting patterns. We contacted the authors of all 16 studies and invited them to contribute deidentified primary data. The Research Ethics Committee of the Jewish General Hospital in Montreal, Quebec, Canada, approved the study.
Data preparation
From the publications associated with each primary study, we extracted information on study country, setting, reference standard, and the cutoffs for which accuracy results were reported. From each primary data set, we extracted PHQ-9 scores and MDD diagnostic status for each patient, as well as information pertaining to weighting. For studies in which sampling procedures merited weighting but the investigators in the original study did not weight the data (30, 31), we constructed appropriate weights using inverse selection probabilities. This occurred, for instance, when all patients with positive screens but only a random subset of patients with negative screens were administered a diagnostic interview.
We compared patient characteristics and published diagnostic accuracy results with results obtained using the raw data sets. When primary data and original publications were discrepant, we resolved discrepancies in consultation with the original investigators. When 2 × 2 tables in study publications could not be reproduced using the data due to errors in the publications, we corrected the published results using the raw data and confirmed the changes with the authors (see Web  Table 1 , available at http://aje.oxfordjournals.org/). We used corrected results because our objective was to evaluate differences in estimates obtained when including all cutoffs versus only some cutoffs, not the extent or influence of unintentional error.
Data analysis
First we performed a conventional meta-analysis in which, for each cutoff from 7 to 15, we included data from the studies that reported results for the cutoff in the original publications. For instance, if a study published results for cutoffs of 9-13, study data were included in our meta-analyses of cutoffs 9-13 but not in our meta-analyses of cutoffs 7, 8, 14, and 15. Second, we performed an IPD meta-analysis in which, for each cutoff from 7 to 15, we included data from all studies.
For both meta-analyses, bivariate random-effects models were fitted via Gauss-Hermite adaptive quadrature, as described by Riley et al. (32) , for cutoffs 7-15 separately. This approach models sensitivity and specificity at the same time, accounting for the inherent correlation between them and for the precision of estimates within studies. A random-effects model was used so that sensitivity and specificity were assumed to vary across primary studies. For each cutoff, for conventional and IPD meta-analyses separately, this model provided an estimate of overall pooled sensitivity and specificity. In order to examine differences in results produced by conventional and IPD meta-analyses, we used the results of the random-effects metaanalyses at each cutoff to construct separate pooled receiver operating characteristic curves for each method.
Accuracy estimates using published data versus all data
We compared sensitivity and specificity estimates based on published results with estimates obtained using all data. To do this, we calculated differences in sensitivity and specificity estimates between the 2 methods at each cutoff. Confidence intervals for the differences were constructed via the "cases bootstrap" approach, as described by van der Leeden et al. (33, 34 ), resampling at the study level and the subject level.
Reporting patterns
We assessed whether primary studies tended to preferentially report accuracy results for low or high cutoffs depending on their optimal cutoff point. In each primary study, we defined the optimal cutoff as the cutoff maximizing Youden's J statistic (sensitivity + specificity − 1) (35). Youden's J does not necessarily reflect decision-maker preferences for the use of tests (36) , but it is commonly used to select optimal cutoffs in studies of the accuracy of depression screening tools. For each study, we plotted the optimal cutoff, along with all other cutoffs for which results were published. We noted whether the reported cutoffs tended to be low or high.
Comparison of results from standard and optimal cutoffs
We compared results from our IPD meta-analysis of the standard cutoff of 10 with an additional IPD meta-analysis of results from each primary study's optimal cutoff (i.e., the cutoff that maximized Youden's J). We hypothesized that heterogeneity in sensitivity when all studies used the standard cutoff would be reduced when results from optimal cutoffs were combined but that substantially different optimal cutoffs would be identified across studies. We compared forest plots of sensitivities and specificities using first a cutoff of 10 for each study and then the optimal cutoff for each study. We also quantified heterogeneity by determining the estimated variances of the random effects for sensitivity and specificity (τ 2 ) and estimating R, which is the ratio of the estimated standard deviation of the pooled sensitivity (or specificity) from the random-effects model to the estimated standard deviation of the pooled sensitivity (or specificity) from the fixed-effects model (37) . Additionally, we compared results derived from the optimal cutoff with those from the standard cutoff for studies that reported results from low-value cutoffs, highvalue cutoffs, or only the standard cutoff.
RESULTS
We successfully obtained 13 of 16 eligible data sets ( Table 1 ). The 3 studies for which data were not obtained (23, 38, 39) had been published between 2001 and 2006, and the authors indicated that the data were no longer retrievable. Of the 5,743 total patients and 1,103 depression cases in the 16 eligible studies, we obtained data for 4,589 patients (80%) and 1,037 depression cases (94%). Characteristics of the included studies are shown in Table 1 . Sensitivity and specificity estimates for each cutoff, for each primary study, are shown in Web Table 1 .
As Table 2 shows, 11 of the 13 studies (83% of patients; 70% of MDD cases) published accuracy results for the standard cutoff of 10, whereas for other cutoffs, only 3-6 studies published accuracy results (21%-46% of patients; 14%-53% of MDD cases per cutoff).
As Figure 1 shows, the receiver operating characteristic curve based on published data only ( Figure 1A) illustrates the distortions that occurred due to reporting of results from some cutoffs but not others in primary studies. On the other hand, the receiver operating characteristic curve based on all data ( Figure 1B ) presents a plausible pattern of joint sensitivity and specificity across cutoffs. Youden's J was maximized at a cutoff of 11 based on published data and at the standard cutoff of 10 based on all data.
Accuracy estimates using published data versus all data Table 3 shows discrepancies in sensitivity and specificity for each cutoff based on published data versus all data. For the cutoff of 10, where results were available from 11 of 13 studies, estimates of sensitivity and specificity were similar. For all other cutoffs, where less than half of patient data was available, sensitivity estimates deviated by 5%-15%. For all cutoffs, specificity estimates based on published data and all data were within 1% of each other.
Reporting patterns
Cutoff reporting patterns from the 13 primary studies are shown in Figure 2 . In studies where the PHQ-9 was poorly Abbreviations: CI, confidence interval; IPD, individual patient data; MDD, major depressive disorder; PHQ-9, Patient Health Questionnaire-9. a 10 is the standard cutoff for identifying MDD with PHQ-9 (8, (10) (11) (12) (13) (14) . b For all cutoffs, the number of studies was 13, the number of patients was 4,589, and the number of MDD cases was 1,037.
sensitive at the standard cutoff of 10 (sensitivity = 0.47-0.75) (30, (40) (41) (42) (43) , optimal cutoffs were less than 10. In these studies, accuracy results tended to be reported for low cutoff values up to the standard of 10. In studies where the PHQ-9 was highly sensitive at the standard cutoff (sensitivity = 0.88-1.00) (31, (44) (45) (46) (47) , optimal cutoffs were greater than 10, with one exception in which cutoffs 10 and 11 performed equivalently (44) . In these studies, results tended to be reported for the standard cutoff of 10 and above. Three studies reported accuracy results for only the standard cutoff of 10 (48-50). Of these studies, 2 (49, 50) had good sensitivity (0.91 and 0.93) and specificity (0.89 and 0.85), whereas the third (48) had low sensitivity (0.75) and good specificity (0.91).
As Table 3 shows, this pattern of reporting results from cutoffs close to the optimal cutoff in each study led to underestimation of sensitivity in published data for cutoffs less than 10 and overestimation for cutoffs greater than 10. All primary studies published results from the study-specific optimal cutoff, and 7 of the 13 studies published results from only 1-3 cutoffs in the cutoff range of 4-16.
Comparison of results from standard and optimal cutoffs
Forest plots of sensitivity estimates obtained using the standard cutoff of 10 for all studies ( Figure 3A) versus the optimal cutoff for each study ( Figure 3B ) are shown in Figure 3 , while those for specificity estimates are shown in Figures 4A and 4B , respectively. There was relatively low heterogeneity in specificity estimates ( Figure 4A : cutoff of 10, τ 2 = 0.18, R = 2.68; Figure 4B : optimal cutoff, τ 2 = 0.46, R = 4.71). However, there was a high degree of heterogeneity in sensitivity estimates using a cutoff of 10 for all studies (25) . Cells shaded in gray represent cutoff points for which diagnostic accuracy results were reported in the original articles. Cells marked with an "O" represent each study's optimal cutoff (the cutoff maximizing Youden's J). For the Azah et al. study (30) , the optimal cutoff determined in the original study was determined using unweighted data and based on "any depression" rather than major depressive disorder. This table replicates the original decision on the cutoffs for which accuracy results were published. In their study, de Lima Osório et al. (44) published accuracy results for cutoffs 10-21. For the study by Yeung et al. (31) , the optimal cutoff was determined using unweighted data rather than weighted data, as the original study did not include weighted analyses. (48-50) and the 1 study in which cutoffs of 10 and 11 performed equivalently (44), estimated sensitivity was 0.94 (95% CI: 0.77, 0.99) and estimated specificity was 0.92 (95% CI: 0.84, 0.96). Sensitivity, specificity, and Youden's J for each primary study, based on the standard cutoff and the optimal cutoff, are shown in Web Table 2 .
DISCUSSION
This is the first study, to our knowledge, that has used IPD meta-analysis to examine selective cutoff reporting patterns in studies of diagnostic test accuracy. Using studies from the most recently published meta-analysis of the PHQ-9 (25), we compared published findings from primary studies, most of which reported results from only a subset of potentially relevant cutoff points, with findings obtained using IPD meta-analysis, where results from all relevant cutoffs for all studies were included.
For the standard PHQ-9 cutoff score of 10, accuracy results were published by 11 of 13 included studies. Sensitivity and specificity estimates were similar using published results and using all data. For all other cutoffs evaluated, however, fewer than half of the studies published accuracy results. For those cutoffs, specificity estimates were similar across the 2 meta-analytical methods but sensitivity estimates differed by 5%-15%. Studies in which the PHQ-9 was poorly sensitive at the standard cutoff of 10 identified optimal cutoffs less than 10 and tended to publish results from only lower cutoff scores up to the cutoff of 10. On the other hand, studies in which the PHQ-9 was highly sensitive at a cutoff of 10 identified optimal cutoffs greater than 10 and tended to publish results for cutoffs of 10 and above. When only published data were considered, sensitivity was underestimated for cutoffs below 10 but overestimated for cutoffs above 10. As a result, instead of seeing reductions in sensitivity as cutoff severity increased, the published data suggested an implausible increase in sensitivity estimates.
When we compared all primary studies using the same cutoff score of 10, there was substantial heterogeneity in sensitivity estimates. When we evaluated each study using the optimal cutoff, sensitivity estimates were generally homogeneous, but optimal cutoffs across studies ranged from 5 to 15, a range far too wide to meaningfully help clinicians determine how to use the PHQ-9 in practice.
The standard cutoff score of 10 for the PHQ-9 was based on only 41 cases from the first PHQ-9 study (23, 29) . Subsequent studies did not report accuracy results from other cutoffs consistently enough to compare accuracy across cutoffs, but the IPD meta-analysis results suggest that a score of 10 may maximize combined sensitivity and specificity. The purpose of this study, however, was not to identify the cutoff that maximizes sensitivity and specificity. It is possible that when additional data are accumulated, this result may not be replicable. Other depression screening tools have standard cutoffs that were also determined using small numbers of patients and have not been revised as evidence has accrued. For instance, the standard cutoff of 11 for "definite" cases of depression in the Hospital Anxiety and Depression Scale, which is the most commonly used depression screening tool in medically ill patients (51, 52) , was based on 12 cases, while the cutoff of 8 or higher for "probable" cases was based on 22 cases (22) . One meta-analysis of the Hospital Anxiety and Depression Scale excluded 16 of 41 (39%) otherwise eligible studies because they reported results for only optimal cutoffs, not results from either of the standard cutoffs (8 and 11) (24) . Other meta-analyses of the Hospital Anxiety and Depression Scale integrated results from different cutoffs into the same meta-analysis as if all studies had used the same cutoff, including many studies that only published accuracy results for nonstandard optimal cutoffs, making it impossible to compare accuracy across cutoffs (53, 54) .
Outside of mental health, simulation studies have demonstrated that using data-driven cutoff thresholds to estimate diagnostic accuracy generates overly optimistic estimates, particularly when sample sizes are small (55, 56) . We were able to identify only 1 meta-analysis that attempted to compare sensitivity and specificity from studies that used data-driven optimal cutoffs versus those that used predetermined cutoffs.
In that study, which evaluated D-dimer for suspected deep vein thrombosis, estimates of sensitivity, but not specificity, were significantly higher in studies that used data-driven cutoffs (57) . However, the determination of whether a primary study cutoff was predetermined versus data-driven was based on author report in the primary studies, and the wide range of cutoffs described as "a priori" suggests that some may not actually have been established as target cutoffs in advance. Among 91 analyses using an enzyme-linked immunoassay test, the 76 cutoff points described as a priori ranged from 40 ng/mL to 1,000 ng/mL, while the 11 described as post hoc ranged from 50 ng/mL to 2,000 ng/mL. In 4 analyses, there was no indication of how the cutoff was determined.
Riley et al. (58) have developed models for dealing with missing threshold data in meta-analyses of diagnostic test accuracy. These models, however, assume that missing data are missing at random. Thus, they cannot be used in situations where selective cutoff reporting is apparent, as the missingness within the studies is not random. Version 2 of the Quality Assessment of Diagnostic Accuracy Studies tool (59) includes an item assessing whether reported cutoffs were chosen a priori or post hoc; however, this classification is based solely on how authors report that they chose their cutoffs. In studies where index test data are ordinal, as is the case with depression screening tools, one potential solution for overcoming selective reporting is to require all authors to provide diagnostic accuracy data (e.g., sensitivity, specificity, positive predictive value, and negative predictive value; or, alternatively, 2 × 2 raw tables of true positives, false positives, true negatives, and false negatives) for all potentially relevant cutoffs in an appendix. In studies where the index test is continuous, a potential solution is to require authors to make their data publicly available upon publication, which is already expected in some journals. IPD meta-analyses can also be used, but they are time-and resource-intensive, and their quality depends on the ability to obtain representative data (60) .
A potential limitation of our study is that we were unable to acquire data for 3 eligible studies included in the original meta-analysis that we replicated. However, we were able to include data for 80% of patients and 94% of cases from the original meta-analysis. Our IPD meta-analysis included data from over 4,500 patients, including more than 1,000 depression cases. More primary studies using the PHQ-9 have been conducted subsequently, however, and ideally our findings will be replicated in larger samples and with other screening tools. Additionally, it should be noted that while we preformed our study under the assumption that authors selected cutoffs to maximize Youden's J, it may be the case that other processes were used in primary studies, such as selecting the highest possible threshold that would preserve some minimal level of sensitivity.
The objective of our study was to replicate an existing meta-analysis that included only published data and to examine how selective reporting of results from some cutoffs and not others influences estimates of diagnostic accuracy. The intent was not to evaluate the accuracy of the PHQ-9 or to examine potential sources of heterogeneity in accuracy estimates. Thus, consistent with the original meta-analysis, we did not evaluate the quality of primary studies, conduct moderator analyses, or seek to explain interstudy heterogeneity. Currently, work has begun on identifying and gathering primary data with which to conduct a full IPD meta-analysis of the PHQ-9 (61), which will address these considerations.
In summary, this study demonstrated that in the presence of selective cutoff reporting, when there is a cutoff considered "standard," estimates of sensitivity may be systematically underestimated for cutoffs below the standard and overestimated for cutoffs above the standard. Because standard cutoffs often originate from preliminary studies with few cases, selective reporting in subsequent studies may impede our ability to use conventional evidence synthesis methods to identify optimal cutoff scores. More work is needed to understand the influence of selective cutoff reporting in studies of the diagnostic test accuracy of depression screening tools and in studies of other types of tests. Users of meta-analyses should be aware of the possibility that metaanalyses based on published data alone may not accurately portray diagnostic accuracy. Similar to movements towards open data access in other fields of research, researchers should routinely report diagnostic test accuracy results for all relevant cutoffs or make data accessible upon publication.
